| Authors: |
Gregg EW; 1School of Population Health, RRCSI University of Medicine and Health Sciences, Dublin, Ireland.; 2Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, U.K., Patorno E; 3Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Karter AJ; 4Division of Research, Kaiser Permanente, Oakland, CA.; 5Department of Health Systems and Population Health, University of Washington, Seattle, WA., Mehta R; 6Metabolic Research Unit (UIEM), Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran (INCMNSZ), Mexico City, Mexico., Huang ES; 7Section of General Internal Medicine, Center for Chronic Disease Research and Policy (CDRP), The University of Chicago, Chicago, IL., White M; 8Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, U.K., Patel CJ; 9Department of Biomedical Informatics, Harvard Medical School, Boston, MA., McElvaine AT; 10Research and Scientific Programs, American Diabetes Association, Arlington, VA., Cefalu WT; 11Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, MD., Selby J; 12Patient-Centered Outcomes Institute, Washington, DC., Riddle MC; 13Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, OR., Khunti K; 14Leicester Real World Evidence Unit, Diabetes Research Centre, University of Leicester, Leicester, U.K. |
